Developing new drugs for hearing disorders
Official title: Drug Discovery and Delivery Core
Funded at Creighton University · NIH-11061762 · Data updated 2026-11-12
This study is working on developing new and better medications for hearing problems, and it's for anyone who struggles with these issues, as well as for future researchers who want to help in this important area.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Creighton University NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project start | March 5, 2021 |
| Project end | January 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $106,487 |
| NIH project number | 5P20GM139762-05 |
| Project ID | NIH-11061762 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals experiencing auditory disorders, including hearing loss or other related conditions.
✕Less likely to help
Patients with auditory disorders that are not amenable to pharmacological intervention may not benefit from this research.
What this research studies
This research focuses on creating effective medications for auditory disorders, which are often overlooked in medical research. The Drug Discovery & Delivery Core (DDDC) at Creighton University aims to establish a comprehensive drug development pipeline that includes advanced screening methods to identify potential new therapies. By collaborating with various research leaders and institutions, the DDDC will also optimize drug compounds and improve delivery methods to ensure they work effectively in the body. This initiative not only seeks to advance treatment options but also aims to train the next generation of researchers in this critical field.
Why it matters
Potential benefit: If successful, this research could lead to new and effective treatments for individuals suffering from auditory disorders.
How similar studies have gone: While there is limited research specifically targeting auditory disorders, similar drug discovery approaches have shown promise in other fields, indicating potential for success in this area.
Where this research is happening
-
Creighton University
Omaha, United States Active
Researchers
- Principal investigator: Zuo, Jian — Creighton University
- Study coordinator: Zuo, Jian
Related research
Other NIH-funded projects on the same topics.
-
Epigenetic control of brain development and behavior linked to KMT5B
A study to understand how changes in a gene called KMT5B affect brain development and behaviors related to autism, by looking at how this gene influences IGF signals in the brain and body.
-
Noise-related hearing loss and brain-to-ear feedback in hearing protection
A small, patient-friendly study will look at how loud noise changes the brain’s control over hearing and whether this affects conditions like tinnitus or sensitivity to sound.
-
Identifying which drugs used for infections and inflammation may harm hearing
Researchers are using computer models and animal studies to flag medicines that could cause hearing loss, with the goal of safer treatments for adults.
-
Redox regulation of Borrelia burgdorferi infectivity
Scientists are studying how the Lyme disease bacteria use redox signals to become infectious, with the aim of understanding how to prevent infection.
-
How prion strains might jump species and change over time
This research will explore how different prion strains and substrains could influence the spread of prion diseases to new animal hosts and possibly humans.
-
New approach to calm the airways in therapy-resistant asthma
A new small-molecule treatment targeting p63RhoGEF could reduce airway tightness and inflammation in people with asthma that doesn’t respond well to standard therapies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.